The Bill & Melinda Gates Foundation has pledged $125 million to speed up global efforts to find a viable vaccine for COVID-19.

Interesting EngineeringBy Brad Bergan

© Kjetil Ree / WikiMedia | Bill & Melinda Gates Foundation Announces $125 Million COVID-19 Therapeutics Accelerator

Mark Suzman CEO at Bill & Melinda Gates Foundation wrote a blog post on LinkedIn Pulse, a business blog, where he announced a $125 million fund called the COVID-19 Therapeutics Accelerator to accelerate the interdisciplinary push to curb the spread of the deadly coronavirus.

$125 million pledged to COVID-19 therapeutics accelerator

In a joint-venture with Wellcome Trust and Mastercard, the Bill & Melinda Gates Foundation is stepping-up financial efforts to combat the novel coronavirus, to the tune of $125 million, said Mark Suzman in the professional blog, LinkedIn Pulse. The funds are to help identify and move up the timetable for possible COVID-19 treatments and help the world prepare to manufacture millions of doses for global use.
Pharmaceutical companies will be crucial for this endeavor, argues Suzman, called the COVID-19 Therapeutics Accelerator.

Curbing the coronavirus epidemic

Epidemics present the world community with a paradoxical set of challenges. Rampant viruses like COVID-19 spread rapidly while the schedule for developing vaccines and treatments to fight their proliferation moves slowly. Suzman argues that if we want to make the most vulnerable people safer from outbreaks, then we need to "unwind" this paradox, which means speeding up R&D and slowing down the spread, said Suzman.
It sounds like a truism to say that antiviral drugs are the only way to fight COVID-19, but it's relevant when, as Suzman suggests, all we can do without functional antiviral medications capable of treating a range of disparate conditions is treat symptoms. What we need, he suggests, is a solution similar to what antibiotics do for bacterial infections.
This article was originally published by Interesting Engineering.
Previous Post Next Post